BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12702999)

  • 1. Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients.
    Ebied O; Federle MP; Blachar A; Brancatelli G; Grazioli L; Cazals-Hatem D; Dondero F; Vilgrain V
    J Comput Assist Tomogr; 2003; 27(2):117-24. PubMed ID: 12702999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy.
    Wee A; Nilsson B
    Acta Cytol; 1999; 43(2):131-8. PubMed ID: 10097699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
    Kashihara T; Ohki A; Kobayashi T; Sato T; Nishizawa H; Ogawa K; Tako H; Kawakami F; Tsuji M; Tamaoka K
    J Gastroenterol; 1998 Jun; 33(3):447-53. PubMed ID: 9658330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO; Jun DW; Jang K
    Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Presentation of Advanced Intrahepatic Cholangiocarcinoma: When Biopsy Results Fail.
    Tasch JJ; Dube N
    Am J Case Rep; 2018 Jan; 19():35-40. PubMed ID: 29317591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT.
    Phongkitkarun S; Srisuwan T; Sornmayura P; Jatchavala J
    J Med Assoc Thai; 2007 Jan; 90(1):113-20. PubMed ID: 17621741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H
    Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
    Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
    Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings.
    Liu QY; Huang SQ; Chen JY; Li HG; Gao M; Liu C; Liang BL
    Abdom Imaging; 2010 Oct; 35(5):537-42. PubMed ID: 19763681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
    Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
    BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
    Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.
    Kim TH; Kim H; Joo I; Lee JM
    Korean J Radiol; 2020 Oct; 21(10):1115-1125. PubMed ID: 32729276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.